Oculis Holding AG (OCS) Enterprise Value (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Enterprise Value came in at -$283.5 million in Q1 2026, down 40.12% year-on-year from -$473.5 million in Q1 2025, and down 6.39% quarter-over-quarter from -$266.5 million in Q4 2025.

Oculis Holding AG (OCS) Enterprise Value (2021 - 2026) Analysis & Trends

Oculis Holding AG's Enterprise Value history runs 6 years deep, the most recent figure standing at -$283.5 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 40.12% year-over-year to -$283.5 million in Q1 2026; TTM through Mar 2026 was -$283.5 million, a 40.12% decrease from a year earlier, with the FY2025 full-year figure at -$256.9 million, down 129.09% from the prior year.
  • Enterprise Value eased to -$283.5 million in Q1 2026 per OCS's latest filing, from -$266.5 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $51.1 million in Q3 2023 and bottomed at -$283.5 million in Q1 2026.
  • The 5-year median for Enterprise Value is -$121.7 million (2024), against an average of -$115.5 million.
  • Across the five-year window, Enterprise Value surged 186.92% in 2023 and plunged 730.86% in 2024, its largest moves.
  • Year by year, Enterprise Value stood at -$20.5 million in 2022, then surged by 186.92% to $17.9 million in 2023, then sank by 730.86% to -$112.6 million in 2024, then sank by 136.64% to -$266.5 million in 2025, then decreased by 6.39% to -$283.5 million in 2026.
  • Per Business Quant, the three latest OCS Enterprise Value figures stand at -$283.5 million (Q1 2026), -$266.5 million (Q4 2025), and -$181.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -283.54 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.83 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -4.79 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -7.25 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -8.75 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -1.91 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -3.01 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -283.54 Mn
Dec 31, 2025 -266.52 Mn
Sep 30, 2025 -181.49 Mn
Jun 30, 2025 -193.62 Mn
Mar 31, 2025 -202.35 Mn
Dec 31, 2024 -112.63 Mn
Sep 30, 2024 -121.74 Mn
Jun 30, 2024 -130.40 Mn
Mar 31, 2024 -91.58 Mn
Dec 31, 2023 17.85 Mn
Sep 30, 2023 51.11 Mn
Jun 30, 2023 33.53 Mn
Dec 31, 2022 -20.54 Mn
Dec 31, 2021 -50.19 Mn